Cipla receives USFDA approval for generic Dacogen
Cipla has received final approval for generic version of Dacogen, from the US health regulator, which is suggested for treatment of myelodysplastic syndromes. Cipla in...
Tag : Cipla
Yes Bank, IndusInd bank will substitute Cipla, Lupin in BSE Sensex
Asia Index today stated that, IndusInd Bank and Yes Bank will enter into the BSE’s benchmark index from December 18, 2017, while Cipla and Lupin...
Cipla Outlook for the Week (Nov 20, 2017 – Nov 24, 2017)
EquityPandit’s Outlook for Cipla for the week (Nov 20, 2017 – Nov 24, 2017) : CIPLA: CIPLA closed the week on absolutely flat note....
Cipla receives final approval for anti-asthma product from USFDA
US health regulator has given final approval to Cipla, for a suspension product used for treating asthma. Cipla in a BSE filing today stated, “it...
Cipla Outlook for the Week (Nov 13, 2017 – Nov 17, 2017)
EquityPandit’s Outlook for Cipla for the week (Nov 13, 2017 – Nov 17, 2017) : CIPLA: CIPLA closed the week on negative note losing...
Cipla reports 19% YoY increase in Q2 profit
Cipla has reported 19.26% YoY increase in consolidated profits at Rs.422.59 crore for the Q2, against Rs.354.34 crore in the same quarter previous year. Total income...
Cipla Outlook for the Week (Nov 06, 2017 – Nov 10, 2017)
EquityPandit’s Outlook for Cipla for the week (Nov 06, 2017 – Nov 10, 2017) : CIPLA: CIPLA closed the week on positive note gaining...
Cipla Outlook for the Week (Oct 30, 2017 – Nov 03, 2017)
EquityPandit’s Outlook for Cipla for the week (Oct 30, 2017 – Oct 03, 2017) : CIPLA: CIPLA closed the week on positive note gaining...
Cipla gets approval for generic version of Renvela tablets from USFDA
Cipla’s subsidiary InvaGen Pharmaceuticals Inc has received nod from the US health regulator for Sevelamer Carbonate tablets, which are suggested for the control of serum phosphorus in...
Cipla Outlook for the Week (Oct 23, 2017 – Oct 27, 2017)
EquityPandit’s Outlook for Cipla for the week (Oct 23, 2017 – Oct 27, 2017) : CIPLA: CIPLA closed the week on positive note gaining...